Gene-Modified Pancreas Cells — No Immunosuppression

Type: gene_therapy

Status: Investigational

Developer: Academic Consortium

Breakthrough Summary

Single-patient proof-of-concept: genetically engineered pancreatic cells survive transplantation WITHOUT immunosuppression drugs. Potentially offers a functional cure for T1D.

Mechanism of Action

Genetically engineered pancreatic cells modified to evade immune detection while producing insulin

Year: 2026